Durisala Desaiah

First-in-Human Dose Study of the Novel Transforming Growth Factor-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Patients with Advanced Cancer and Glioma

J. Baselga, J. Seoane, L. Paz-Ares, 2014, Clinical Cancer Research.

Fire Ant Venom Alkaloid, Isosolenopsin A, a Potent and Selective Inhibitor of Neuronal Nitric Oxide Synthase

R. V. Vander Meer, R. Rockhold, J. Moffitt, 2003, International journal of toxicology.